Net profit of RPG Life Sciences rose 777.38% to Rs 36.85 crore in the quarter ended September 2025 as against Rs 4.20 crore during the previous quarter ended September 2024. Sales rose 5.50% to Rs 181.68 crore in the quarter ended September 2025 as against Rs 172.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales181.68172.21 5 OPM %21.4826.67 - PBDT43.4547.70 -9 PBT38.2342.39 -10 NP36.854.20 777 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live News

Net profit of RPG Life Sciences declined 1.76% to Rs 26.29 crore in the quarter ended June 2025 as against Rs 26.76 crore during the previous quarter ended June 2024. Sales rose 2.12% to Rs 168.92 crore in the quarter ended June 2025 as against Rs 165.42 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales168.92165.42 2 OPM %21.0023.62 - PBDT40.5741.29 -2 PBT35.4336.00 -2 NP26.2926.76 -2 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 25 July 2025.Powered by Capital Market - Live News

RPG Life Sciences announced that the 18th Annual General Meeting(AGM) of the company will be held on 16 July 2025.Powered by Capital Market - Live News